Dan Buskila

Prof. Dan Buskila


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
Jacob AblinJacob Ablin
Jacob Ablin
DBDan Buskila
Dan Buskila

17 May 2023 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
APAna M Pinto
Ana M Pinto
MLMariana Luís
Mariana Luís
RGRinie Geenen
Rinie Geenen
FPFilipe Palavra
Filipe Palavra
MLMark A. Lumley
Mark A. Lumley
JSJosé A.P. da Silva
José A.P. da Silva

1 January 2009 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
DBDan Buskila
Dan Buskila
Our understanding of fibromyalgia (FM) has made significant advances over the past decade. The current concept views FM as the result of central nervous system malfunction resulting in amplification of pain transmission and interpretation. Research done over the past years has demonstrated a role for polymorphisms of genes in the serotoninergic, dopaminergic and catecholaminergic systems in the etiopathogenesis of FM. Various external stimuli such as infection, trauma and stress may contribute to the development of the syndrome. The management of FM requires an integrated approach combining pharmacological and nonpharmacological modalities. The recent Food and Drugs Administration approval of pregabalin, duloxetine and milnacipran as medications for FM may herald a new era for the development of medications with higher specificity and efficacy for the condition. As our understanding of the biological basis and the genetic underpinning of FM increases, we hope to gain a better understanding of the true nature of the disorder, to better classify patients and to attain more rational therapeutic modalities.

1 May 2009 in Rheumatic Disease Clinics of North America
Verified
Journal Article
Closed access
DBDan Buskila
Dan Buskila

LCLiraz Cohen-biton
Liraz Cohen-biton
DBDan Buskila
Dan Buskila
RGRachel Nissanholtz Gannot
Rachel Nissanholtz Gannot
Background: Fibromyalgia (FM) is a disease characterized by widespread musculoskeletal chronic pain that impairs the patient’s quality of life and is considered a somatization disorder. The symptoms of the disease also affect the patient mentally, mainly since invisible pain is the only thing that indicates its existence. A typical symptom that characterizes FM patients is the lack of acceptance of the disease since its pathophysiology is not elucidated, hence the deficiencies in its management, or rather, cognitively, the belief that there is no disease to manage. The current paper aims to shed light on the new treatment methods at a holistic level, that is, cognitive, physical, and pharmacological therapies. Method: A literature review was carried out that discusses treatment methods that help alleviate the pain, accept it, and manage the symptoms of the disease. Results: FM symptoms can be treated by taking a broad view of treatment that will include a response to the mind through pain management, response to the body through physical activity, and response to the pain through pharmacological treatment. Conclusions: Today, there is an evolutionary view that accepts FM and chronic pain diseases as syndromes in which the pain is the disease; therefore, the response to this disease can be applied through three channels: physical, bodily, and mental.

1 July 2009 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
RCRoberto Casale
Roberto Casale
Piercarlo Sarzi-PuttiniPiercarlo Sarzi-Puttini
Piercarlo Sarzi-Puttini
FAFabiola Atzeni
Fabiola Atzeni
MGMARCO GAZZONI
MARCO GAZZONI
DBDan Buskila
Dan Buskila
Alberto RainoldiAlberto Rainoldi
Alberto Rainoldi
Fibromyalgia (FM) is characterised by diffuse musculoskeletal pain and stiffness at multiple sites, tender points in characteristic locations, and the frequent presence of symptoms such as fatigue. The aim of this study was to assess whether the myoelectrical manifestations of fatigue in patients affected by FM are central or peripheral in origin.